While shRNA-mediated knockdown of Il1rl1 did not alter the proliferation or migration of CT26 CRC cells in vitro, these cells developed larger tumors when injected into the flanks of immunocompetent recipient mice. Here, IL1RL1 is linked to colorectal carcinoma.